The Moffitt Cancer Centers trial adjusted abiraterone dosing based on PSA/testosterone dynamics, delaying resistance and reducing toxicity
This dual mechanism makes it particularly effective for patients whose weight gain is driven by emotional eating, food cravings, or the "reward" component of overeating
Weeks 2 to 6 Pigmentation is commonly described as building steadily over this window, with the deepest color reported around four to six weeks of continued use
Unfortunately small clinical trials of glutathione itself and of acetylcysteine showed no significant benefit
Recent data indicate that UC affects approximately 5 million individuals worldwide as of 2023, with a steadily rising incidence rate (Le Berre et al., 2023)
S., Nieuwenhuizen, A., Tome, D., Soenen, S., & Westerterp, K